1. Home
  2. GAUZ vs VTYX Comparison

GAUZ vs VTYX Comparison

Compare GAUZ & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • VTYX
  • Stock Information
  • Founded
  • GAUZ 2009
  • VTYX 2018
  • Country
  • GAUZ Israel
  • VTYX United States
  • Employees
  • GAUZ N/A
  • VTYX N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • VTYX Medicinal Chemicals and Botanical Products
  • Sector
  • GAUZ Miscellaneous
  • VTYX Health Care
  • Exchange
  • GAUZ Nasdaq
  • VTYX Nasdaq
  • Market Cap
  • GAUZ 152.3M
  • VTYX 154.9M
  • IPO Year
  • GAUZ 2024
  • VTYX 2021
  • Fundamental
  • Price
  • GAUZ $6.77
  • VTYX $2.77
  • Analyst Decision
  • GAUZ Strong Buy
  • VTYX Buy
  • Analyst Count
  • GAUZ 3
  • VTYX 4
  • Target Price
  • GAUZ $14.67
  • VTYX $11.33
  • AVG Volume (30 Days)
  • GAUZ 505.8K
  • VTYX 1.9M
  • Earning Date
  • GAUZ 08-07-2025
  • VTYX 08-07-2025
  • Dividend Yield
  • GAUZ N/A
  • VTYX N/A
  • EPS Growth
  • GAUZ N/A
  • VTYX N/A
  • EPS
  • GAUZ N/A
  • VTYX N/A
  • Revenue
  • GAUZ $101,165,000.00
  • VTYX N/A
  • Revenue This Year
  • GAUZ $28.49
  • VTYX N/A
  • Revenue Next Year
  • GAUZ $47.77
  • VTYX N/A
  • P/E Ratio
  • GAUZ N/A
  • VTYX N/A
  • Revenue Growth
  • GAUZ 18.63
  • VTYX N/A
  • 52 Week Low
  • GAUZ $5.50
  • VTYX $0.78
  • 52 Week High
  • GAUZ $13.00
  • VTYX $3.39
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • VTYX 62.76
  • Support Level
  • GAUZ N/A
  • VTYX $1.95
  • Resistance Level
  • GAUZ N/A
  • VTYX $2.51
  • Average True Range (ATR)
  • GAUZ 0.00
  • VTYX 0.17
  • MACD
  • GAUZ 0.00
  • VTYX -0.02
  • Stochastic Oscillator
  • GAUZ 0.00
  • VTYX 104.37

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: